Shares RSIs, highs and lows

Our regular look at shares trading at significant levels.

Supergroup’s 14% slump yesterday has carried it into oversold levels, after the company said that sales had been hit hard by a late Easter and a reduction in sales through the online auction site eBay. We saw the shares slump 20% in April, as this high growth and high momentum stock fell out of favour with investors. Last year was a good one for the company, so it is admittedly struggling against difficult comparisons, but the slowdown in volumes is worrying news.

Gold miner Petropavlovsk is also oversold, and rapidly heading towards a retest of the 65p low that was seen in January. A drop through here means we could see the shares fall to 55p, the all-time low in what was a very impressive downtrend.

Relative Strength Index (RSI)*


Share Price



Share Price


Salamander Energy 144.75 87.92 Balfour Beatty 225 21.17
BG Group 1274 86.67 SuperGroup 1161 23.12
InterContinental Hotels Group 2221 81.44 Chemring Group 217.25 25.21
Provident Financial 2095 79.62 CSR  563.5 27.17
Royal Dutch Shell 2368 77.89 WS Atkins 1257 28.38
Heritage Oil 315.2 74.59 Serco Group 346.4 28.44
Premier Oil 341 72.66 Petropavlovsk  66.25 29.64


Copper miner Antofagasta has finished with its latest bounce and is now dropping back towards 52-week lows. Although the price of the red metal has gained in recent weeks concerns about output from Antofagasta remain, and this is driving the share price lower. In my view, 765p and the 750p are the short term targets on the downside to watch.



Share Price

% off 52-week high


Share Price

% off 52-week low

AZ Electronic Materials SA 410 0.00% Mothercare 164 1.39%
National Grid 847.5 -0.24% Experian 1053 3.24%
Imperial Tobacco Group 2596 -0.35% Centrica 315.8 4.40%
InterContinental Hotels Group 2221 -0.49% Dairy Crest Group 467.3 4.75%
Royal Dutch Shell


-0.71% International Public Partnership 130 5.26%
United Utilities Group 820.5 -0.79% Antofagasta 772.5 5.39%
Heritage Oil 315.2 -0.85% GlaxoSmithKline 1613 5.56%


*What is a relative strength index?

Relative strength index is a technical momentum indicator that compares the magnitude of recent gains to recent losses in an attempt to determine overbought and oversold conditions of an asset.

An asset is viewed as overbought once the RSI approaches the 70 level, meaning that it may be getting overvalued and is a candidate for a possible pullback. Conversely, if the RSI approaches 30, it is an indication that the asset may be oversold and may become undervalued.

**What is the significance of 52-week highs and lows?

One popular strategy is to buy when shares exceed 52-week highs and sell when they fall below 52-week lows.

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.